Figure 1.
Factors influencing the selection of definitive therapy in R/R pediatric ALL. The chart graphically represents the many factors that contribute to the cost-benefit analysis of the selection of definitive therapy with the highest chance of clinical success in R/R pediatric patients with ALL.